Every 10-Q that Nortech Systems Inc (NSYS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow NSYS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NSYS filings page.
Nortech Systems Incorporated (NSYS) reported higher sales and a return to profitability for the six months ended June 30, 2026. Net sales rose to $33.5 million for the quarter and $63.9 million year-to-date, up 9.3% and 10.9% from the prior-year periods, driven mainly by strong growth in Medical Device and Medical Imaging markets. For the six-month period, net income improved to $0.3 million from a loss of $1.0 million a year earlier, as gross margin expanded.
Gross profit increased to $10.4 million for the first half of 2026, with gross margin improving to 16.3% from 13.7%, reflecting higher volumes and better manufacturing cost absorption, partially offset by an unfavorable sales mix. Operating income for the first six months was $0.7 million, compared with an operating loss of $0.9 million in the prior-year period, aided by the absence of prior restructuring charges despite higher incentive compensation.
Total assets were $80.0 million and shareholders’ equity $35.5 million at June 30, 2026. The company had $7.9 million of lines of credit and current term debt, supported by a new $15.0 million Associated Bank credit facility and term loan maturing in 2029, with covenant compliance reported. Ninety-day backlog rose to $33.4 million and total backlog to $93.8 million, both higher than a year earlier, signaling continued demand, particularly in Aerospace and Defense.
Nortech Systems reported higher sales and sharply improved profitability for the quarter ended March 31, 2026. Net sales rose to $30,316 from $26,895, led by growth in Medical Imaging and Aerospace and Defense.
Gross profit increased to $4,702, lifting gross margin to 15.5% from 11.4%, as plant utilization improved after prior restructuring. The company posted a small net loss of $34, significantly better than the $1,316 loss a year earlier.
Operating cash outflow narrowed to $1,561, while cash and restricted cash ended at $2,208. A new $15,000 Associated Bank revolving credit facility and a $2,200 term loan, maturing in 2029, refinanced the prior revolver and support liquidity. Total backlog climbed to $90,802, up strongly year over year, with particular strength in Aerospace and Defense.
Nortech Systems (NSYS) filed its Q3 2025 10‑Q, showing net sales of $30.5 million versus $31.4 million a year ago. Gross margin improved to 16.5% from 12.2%, lifting operating results to $0.9 million of operating income from a prior‑year loss. The quarter ended with a net loss of $0.1 million, compared with a $0.7 million loss last year.
Year‑to‑date, net sales were $88.1 million versus $99.5 million, with operating income of $0.1 million and a net loss of $1.1 million. Aerospace and Defense softness and plant transfers weighed on revenue, while Medical Imaging grew. The 90‑day backlog rose to $31.3 million, up 17.8% from the start of the quarter, and total backlog was $77.3 million. Cash was $1.3 million, and the line of credit balance was $12.0 million, classified as current. Management noted that the revolver maturing on August 31, 2026 initially raised substantial doubt under accounting guidance, but term sheets and a refinancing plan alleviated that doubt. Operating cash flow used was $2.9 million for the first nine months.